PetVivo Holdings to Present Innovative Veterinary Therapeutics at Spartan Capital Investor Conference

PetVivo Holdings, Inc. will present at the Spartan Capital Securities Second Annual Investor Conference on November 3, 2025, at the Marriott Marquis Hotel in New York City. This participation underscores the conference's mission to spotlight innovative companies positioned for long-term growth and provides PetVivo with a significant platform to connect with institutional investors and strengthen capital market relationships.

Chief Executive Officer John Lai will provide an overview of the company and discuss its flagship products, SPRYNG with OsteoCushion Technology and PrecisePRP. SPRYNG with OsteoCushion Technology represents an important advancement in veterinary joint care as an intra-articular injectable medical device consisting of sterilized, extra-cellular matrix microparticles. These microparticles have been found to adsorb onto the joint synovial lining of animals and integrate with subsynovial tissue, promoting restoration of proper joint mechanics and aiding in management of noninfectious joint pain sources including joint instability, degenerative joint disease and osteoarthritis.

PrecisePRP marks a significant innovation as a first-in-class off-the-shelf platelet-rich plasma product designed for veterinary use. Unlike traditional PRP mechanical kits that require blood draws and centrifugation, PrecisePRP offers a leucoreduced, allogeneic, pooled, freeze-dried PRP that provides species-specific concentrated platelets for intra-articular administration in dogs and horses. The product guarantees uniformity and consistency with each vial containing a consistent dose of 4 billion platelets at a concentration of 500,000 platelets per microliter, representing a substantial improvement in treatment standardization and convenience for veterinary practitioners.

Spartan Capital Securities Founder and CEO John D. Lowry emphasized the conference's role in connecting growth companies with appropriate investors and resources, noting that the event brings together high-quality issuers and serious capital providers under one roof. Organized in partnership with B2i Digital, the conference will showcase more than 60 carefully selected companies across technology, healthcare, consumer, mining, precious metals and other high-growth sectors, with over 500 institutional and high-net-worth investors expected to attend.

David Shapiro, CEO of B2i Digital, highlighted the broader commitment to connecting investors with diverse growth companies, combining digital marketing reach with face-to-face investor engagement. The event will feature main-stage presentations, expert panels, curated one-on-one meetings and extensive networking sessions, creating meaningful opportunities for dialogue between growth companies and the investment community. For more information about the conference and registration details, please visit https://spartancapital.com.